Drug Trial Radar · NCT06116240
A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors
Last checked: Nov 19, 2026Latest source record: Nov 3, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
135
Planned (sponsor's estimate)
Start
Sep 2, 2022
Primary completion
Dec 2023
Study completion Dec 2023
Sponsor
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Nov 3, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase Ib clinical trial to evaluate the safety and efficacy of TQB2450 injection combined with AL2846 capsules in patients with advanced solid tumors.
Conditions
- Solid Tumor
Interventions
TQB2450 injectionDrug
TQB2450 is a humanized monoclonal antibody targeting programmed death ligand-1 (PD-L1).
AL2846 capsuleDrug
AL2846 is a multi-targeted tyrosine kinase receptor inhibitor
Pemetrexed disodium for injectionDrug
Pemetrexed disodium is a multi-target antifolate antineoplastic drug.
Cisplatin injectionDrug
Cisplatin is a chemotherapy drug.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective response rateTime frame: Baseline up to 96 weeks
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
Jiangmen Central Hospital
Jiangmen, Guangdong, China
Affiliated Hospital of Hebei University
Baoding, Hebei, China
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China
Inner Mongolia Baotou Steel Hospital
Baotou, Neimenggu, China
Shandong First Medical University Affiliated Cancer Hospital
Jinan, Shandong, China
Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, China
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, China
The Second Hospital of Tianjin Medical University
Tianjin, Tianjin Municipality, China
Tianjin Chest Hospital
Tianjin, Tianjin Municipality, China
Tianjin Fifth Central Hospital
Tianjin, Tianjin Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.